DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / GreenMark Biomedical Inc.
GreenMark Biomedical Inc.
Stage unknownEast Lansing, MIBiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
2 rounds
- Apr 14, 2026Form D equity offering · $0 (form d sold)Fact SEC EDGAR Form D data sets (quarterly) · “GreenMark Biomedical Inc. filed Form D: no sales yet of $5,000,000, Biotechnology”
- Jan 21, 2025Form D equity offering · $0 (form d sold)Fact SEC EDGAR Form D data sets (quarterly) · “GreenMark Biomedical Inc. filed Form D: no sales yet of $500,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
1 officers, 3 directors
- Steven Bloembergen Phd Executive Officer/Director sec.gov
- Joerg Lahann, Phd Director Fact
- Michael Snyder Director Fact
- Joerg Lahann, PH.D. Director Fact
Timeline
2
- Apr 14, 2026GreenMark Biomedical Inc. filed Form D: no sales yet of $5,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Jan 21, 2025GreenMark Biomedical Inc. filed Form D: no sales yet of $500,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
25 observations
Every observation on this company
- Entity type: Corporation Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $0 Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $0 Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $5.0M Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $500,000 Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 0 Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 0 Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 25,000 Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 10,000 Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 325 E. GRAND RIVER AVENUE, SUITE 314, EAST LANSING, MI, 48823-4375 Apr 14, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 325 E. GRAND RIVER AVENUE, SUITE 314, EAST LANSING, MI, 48823-4375 Jan 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)